Skip to Main Content

Author Details

Andrew J Evans
Princess Margaret Cancer Center, University Health Network.
1996
219
61
PMIDPaper TitleJournal TitlePublished Year
34003251Validating Whole Slide Imaging Systems for Diagnostic Purposes in Pathology.Arch Pathol Lab Med2022
36270849LOT and HOT ⿦ or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia.Pathology2022
36083240Low-grade prostate cancer should still be labelled cancer.BJU Int2022
35174071Investigating Urinary Circular RNA Biomarkers for Improved Detection of Renal Cell Carcinoma.Front Oncol2022
32152437Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer.Prostate Cancer Prostatic Dis2021
33780691Cribriform prostate cancer: Morphologic criteria enabling a diagnosis, based on survey of experts.Ann Diagn Pathol2021
34243797Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel disease.Radiat Oncol2021
33999555ISUP Consensus Definition of Cribriform Pattern Prostate Cancer.Am J Surg Pathol2021
33206437Prostate cancer grading, time to go back to the future.BJU Int2021
32611763Establishment of a remote diagnostic histopathology service using whole slide imaging (digital pathology).J Clin Pathol2021
32459716The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.Am J Surg Pathol2020
31926806Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.Lancet Oncol2020
32045306Predictive Value of In Vivo MR Spectroscopy With Semilocalization by Adiabatic Selective Refocusing in Differentiating Clear Cell Renal Cell Carcinoma From Other Subtypes.AJR Am J Roentgenol2020
33106861Issues to Consider When Implementing Digital Pathology for Primary Diagnosis.Arch Pathol Lab Med2020
32946287Unsupervised Resolution of Histomorphologic Heterogeneity in Renal Cell Carcinoma Using a Brain Tumor-Educated Neural Network.JCO Clin Cancer Inform2020
32969766Reply by Authors.J Urol2020
32680677Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort.Eur Urol2020
32701148Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy Specimens.JAMA Oncol2020
32496160Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?J Urol2020
32542445Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading.Virchows Arch2020
32561208Granular necrosis: a distinctive form of cell death in malignant tumours.Pathology2020
30325065Data set for the reporting of carcinoma of renal tubular origin: recommendations from the International Collaboration on Cancer Reporting (ICCR).Histopathology2019
31754638Erratum: Publisher Correction: Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer.NPJ Digit Med2019
30160779Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data set.Histopathology2019
31300532Dataset for the reporting of renal biopsy for tumour: recommendations from the International Collaboration on Cancer Reporting (ICCR).J Clin Pathol2019
31279442Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.Pathology2019
31304394Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer.NPJ Digit Med2019
30952818Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC).Oncologist2019
31001920Long-term oncological outcomes of patients with paratesticular sarcoma.BJU Int2019
30763230Are there differences between de novo and secondary upper tract urothelial carcinoma tumours?Can Urol Assoc J2019
30755496Accuracy of renal tumour biopsy for the diagnosis and subtyping of papillary renal cell carcinoma: analysis of paired biopsy and nephrectomy specimens with focus on discordant cases.J Clin Pathol2019
30929849Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate Cancer.Eur Urol Oncol2019
28849944Integrated Pathology Informatics Enables High-Quality Personalized and Precision Medicine: Digital Pathology and Beyond.Arch Pathol Lab Med2018
29875433Statin use and time to progression in men on active surveillance for prostate cancer.Prostate Cancer Prostatic Dis2018
30662792The Importance of eSlide Macro Images for Primary Diagnosis with Whole Slide Imaging.J Pathol Inform2018
29359484Utility of Pathology Imagebase for standardisation of prostate cancer grading.Histopathology2018
29408568Role of Magnetic Resonance Imaging Targeted Biopsy in Detection of Prostate Cancer Harboring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma.J Urol2018
29629862Identifying the use and barriers to the adoption of renal tumour biopsy in the management of small renal masses.Can Urol Assoc J2018
29405912Case - Foamy, high-grade prostatic intraepithelial neoplasia: A false positive for prostate cancer on multiparametric magnetic resonance imaging?Can Urol Assoc J2018
29708429US Food and Drug Administration Approval of Whole Slide Imaging for Primary Diagnosis: A Key Milestone Is Reached and New Questions Are Raised.Arch Pathol Lab Med2018
29758220Evaluation of an Aggressive Prostate Biopsy Strategy in Men Younger than 50 Years.J Urol2018
29297495Treatment effects in prostate cancer.Mod Pathol2018
28753789Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.Eur Urol Focus2018
27457260Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active Surveillance.J Urol2017
28440660Implementation of Whole Slide Imaging for Clinical Purposes: Issues to Consider From the Perspective of Early Adopters.Arch Pathol Lab Med2017
28134585Prostate Cancer Grading: A Decade After the 2005 Modified Gleason Grading System.Arch Pathol Lab Med2017
28130102Variant Histology and Clinicopathological Features of Prostate Cancer in Men Younger than 50 Years Treated with Radical Prostatectomy.J Urol2017
28095147Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline.J Clin Oncol2017
28443144Modern-day prostate cancer is not meaningfully associated with lower urinary tract symptoms: Analysis of a propensity score-matched cohort.Can Urol Assoc J2017
29416756A miRNA-based classification of renal cell carcinoma subtypes by PCR and <i>in situ</i> hybridization.Oncotarget2017
  • 1 - 50 of 219

Recommended Authors

Anthony Sisk
University of California los angeles
Career Start Year 2017
Number of shared co-authors 1
Jamil S Syed
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 2
Neil Mendhiratta
National Cancer Institute, National Institutes of Health
Career Start Year 2013
Number of shared co-authors 2
Jacqueline Fontugne
Institut Curie, CNRS, PSL Research University
Career Start Year 2013
Number of shared co-authors 5
Dibson D Gondim
University of Louisville
Career Start Year 2012
Number of shared co-authors 2
Simpa S Salami
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 9
Steven Hazell
Royal Marsden NHS Foundation Trust
Career Start Year 2011
Number of shared co-authors 5
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Career Start Year 2008
Number of shared co-authors 17
Aydin Pooli
David Geffen School of Medicine, University of California los angeles
Career Start Year 2008
Number of shared co-authors 2
Adam Kinnaird
University of Alberta
Career Start Year 2007
Number of shared co-authors 5
Alastair D Lamb
University of Oxford
Career Start Year 2007
Number of shared co-authors 26
Roula Albadine
Centre hospitalier de l'Universite de Montreal
Career Start Year 2006
Number of shared co-authors 11
Tamara L Lotan
Johns Hopkins University School of Medicine
Career Start Year 2006
Number of shared co-authors 22
Huihui Ye
College of Optical Science and Engineering, Zhejiang University
Career Start Year 2004
Number of shared co-authors 7
Adebowale J Adeniran
Yale School of Medicine
Career Start Year 2003
Number of shared co-authors 4
Ashley E Ross
Northwestern University
Career Start Year 2003
Number of shared co-authors 14
Clare Verrill
NIHR Oxford Biomedical Research Centre
Career Start Year 2002
Number of shared co-authors 9
Lakshmi P Kunju
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2002
Number of shared co-authors 23
Tim Dudderidge
University Hospital Southampton NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 7
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 23
Rohit Mehra
Michigan Center for Translational Pathology.
Career Start Year 2000
Number of shared co-authors 27
Anuradha Gopalan
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 23
Todd M Morgan
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 17
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 13
Sahussapont J Sirintrapun
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 5
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 7
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Career Start Year 1993
Number of shared co-authors 13
Damien Bolton
University of Melbourne
Career Start Year 1988
Number of shared co-authors 11
Cathy Corbishley
The Institute of Cancer Research
Career Start Year 1977
Number of shared co-authors 6
Maria J Merino
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 7

Collaborators

Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 66
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Co-authored papers 66
Neil E Fleshner
University of Toronto
Co-authored papers 61
John R Srigley
University of Toronto
Co-authored papers 38
Ants Toi
Mount Sinai Hospital, University of Toronto
Co-authored papers 37
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Co-authored papers 37
John Trachtenberg
University of Toronto, University Health Network
Co-authored papers 31
Girish S Kulkarni
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 27
Lars Egevad
Karolinska Institute
Co-authored papers 26
Masoom A Haider
University Health Network
Co-authored papers 19
Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 15
Peter A Humphrey
Yale University School of Medicine
Co-authored papers 13
Jeremy A Squire
University of Sao Paulo
Co-authored papers 13
Anthony M Joshua
The Kinghorn Cancer Centre, St. Vincent's Hospital Sydney
Co-authored papers 12
Joseph L Chin
University of Western Ontario
Co-authored papers 7
Geert J L H van Leenders
Erasmus MC Cancer Institute, University Medical Center
Co-authored papers 6
Lawrence D True
University of Washington School of Medicine
Co-authored papers 6
Michelle R Downes
University of Toronto
Co-authored papers 5
Jenna Sykes
St. Michael's Hospital, University of Toronto
Co-authored papers 5
Michael Milosevic
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
Brenda L Gallie
The Eye Cancer Clinic, Princess Margaret Cancer Centre, Hospital for Sick Children
Co-authored papers 5
Cynthia Kuk
Mount Sinai Hospital, University of Toronto, University Health Network
Co-authored papers 5
Robert G Bristow
University of Toronto
Co-authored papers 5
Fadi Brimo
McGill University Health Centre, McGill University
Co-authored papers 5
Martin E Gleave
University of British Columbia
Co-authored papers 5
Holger Moch
University Hospital Zurich
Co-authored papers 4
David Robert Siemens
Queen's University
Co-authored papers 4
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 4
Susan Prendeville
University of Toronto
Co-authored papers 4
Jason D Hipp
Mayo Clinic
Co-authored papers 4
Release 1.2